Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RASHID Z KHAN

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1649446444
CMS profile
695418
Location
MISHAWAKA, IN

General Payments · PY2018–2024

$7,195.37

  • Reported across 161 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$818.62

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $785.18 35
Education $33.44 2

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,194.10 17
PY2019 $211.99 10
PY2020 $1,595.03 8
PY2021 $11.92 1
PY2022 $1,347.12 38
PY2023 $1,016.59 50
PY2024 $818.62 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $29.38 09/05/2024 Food and Beverage Undisputed 01/23/2026 1104061956 CMS
ARRAY BIOPHARMA INC $21.24 06/17/2024 Food and Beverage Undisputed 01/23/2026 1131918983 CMS
Astellas Pharma US Inc $22.70 01/18/2024 Food and Beverage Undisputed 01/23/2026 1139275878 CMS
Astellas Pharma US Inc $24.54 07/02/2024 Food and Beverage Undisputed 01/23/2026 1139283912 CMS
Astellas Pharma US Inc $24.20 07/09/2024 Food and Beverage Undisputed 01/23/2026 1139281076 CMS
Astellas Pharma US Inc $21.47 11/14/2024 Food and Beverage Undisputed 01/23/2026 1139429740 CMS
AstraZeneca Pharmaceuticals LP $27.42 03/12/2024 Food and Beverage Undisputed 01/23/2026 1104380457 CMS
AstraZeneca Pharmaceuticals LP $13.13 09/19/2024 Food and Beverage Undisputed 01/23/2026 1104424627 CMS
Aveo Pharmaceuticals, Inc. $20.00 11/22/2024 Education Undisputed 01/23/2026 1143484891 CMS
Celgene Corporation $27.55 11/07/2024 Food and Beverage Undisputed 01/23/2026 1101156930 CMS
E.R. Squibb & Sons, L.L.C. $27.30 03/05/2024 Food and Beverage Undisputed 01/23/2026 1101569299 CMS
E.R. Squibb & Sons, L.L.C. $27.82 04/16/2024 Food and Beverage Undisputed 01/23/2026 1101569310 CMS
E.R. Squibb & Sons, L.L.C. $27.76 06/20/2024 Food and Beverage Undisputed 01/23/2026 1101569327 CMS
Eisai Inc. $17.31 02/01/2024 Food and Beverage Undisputed 01/23/2026 1110775369 CMS
Genentech USA, Inc. $26.38 02/22/2024 Food and Beverage Undisputed 01/23/2026 1133093722 CMS
Genentech USA, Inc. $29.82 05/02/2024 Food and Beverage Undisputed 01/23/2026 1133093726 CMS
Genentech USA, Inc. $27.29 05/16/2024 Food and Beverage Undisputed 01/23/2026 1133093718 CMS
Genentech USA, Inc. $29.58 05/30/2024 Food and Beverage Undisputed 01/23/2026 1133093730 CMS
Genentech USA, Inc. $27.10 08/22/2024 Food and Beverage Undisputed 01/23/2026 1133093734 CMS
Genentech USA, Inc. $24.64 09/26/2024 Food and Beverage Undisputed 01/23/2026 1133093714 CMS
GENZYME CORPORATION $17.31 08/01/2024 Food and Beverage Undisputed 01/23/2026 1139848212 CMS
GlaxoSmithKline, LLC. $26.08 05/14/2024 Food and Beverage Undisputed 01/23/2026 1116627440 CMS
GlaxoSmithKline, LLC. $16.63 07/30/2024 Food and Beverage Undisputed 01/23/2026 1116662599 CMS
Incyte Corporation $15.17 06/27/2024 Food and Beverage Undisputed 01/23/2026 1141285415 CMS
Merck Sharp & Dohme LLC $25.34 05/23/2024 Food and Beverage Undisputed 01/23/2026 1141800950 CMS
Merck Sharp & Dohme LLC $28.25 10/31/2024 Food and Beverage Undisputed 01/23/2026 1141903614 CMS
Mirati Therapeutics, Inc. $17.78 02/06/2024 Food and Beverage Undisputed 01/23/2026 1117172128 CMS
Novartis Pharmaceuticals Corporation $11.19 02/27/2024 Food and Beverage Undisputed 01/23/2026 1087129034 CMS
Novartis Pharmaceuticals Corporation $0.11 02/27/2024 Food and Beverage Undisputed 01/23/2026 1087129036 CMS
Novartis Pharmaceuticals Corporation $23.06 06/04/2024 Food and Beverage Undisputed 01/23/2026 1087129042 CMS
Novartis Pharmaceuticals Corporation $19.71 07/16/2024 Food and Beverage Undisputed 01/23/2026 1087129046 CMS
Novartis Pharmaceuticals Corporation $13.44 07/17/2024 Education Undisputed 01/23/2026 1087129054 CMS
Novartis Pharmaceuticals Corporation $20.53 08/23/2024 Food and Beverage Undisputed 01/23/2026 1087129048 CMS
Novartis Pharmaceuticals Corporation $31.05 10/17/2024 Food and Beverage Undisputed 01/23/2026 1087129050 CMS
Novartis Pharmaceuticals Corporation $20.57 11/21/2024 Food and Beverage Undisputed 01/23/2026 1087129056 CMS
PFIZER INC. $16.47 01/04/2024 Food and Beverage Undisputed 01/23/2026 1131911775 CMS
PFIZER INC. $19.30 03/19/2024 Food and Beverage Undisputed 01/23/2026 1131299883 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.